WhoIs onlyrxmeds.com

Drug Enforcement Agency

United States of America

The Ryan Haight Act Known as
Online Pharmacy Consumer Protection Act of 2008
Sec. 2. Requirement of a valid prescription for
controlled substances dispensed by means of the Internet.

Who’s Behind These Online Pharmacies

SUMMARY: The Ryan Haight Online Pharmacy Consumer Protection Act,
which was enacted on October 15, 2008,amended the Controlled Substances Act and Controlled Substances Import and Export Act by adding several new provisions to prevent the illegal distribution and dispensing of controlled substances by means of the Internet.
_________________________________

onlyRxMeds.png
screencapture-bgp-he-net-ip-188-226-143-222-1508039161448.png

The following A records are set to 188.226.143.222:

  1. 100pills.net
  2. 247discountmeds.com
  3. 247rxdeals.com
  4. 247rxmeds.net,
  5. 24apoteket.com,
  6. 24drugstore.net,
  7. 33drugs.com,
  8. 365worldstore.com,
  9. 4rx-meds.com,
  10. 7-rx.com,
  11. abspharm.com,
  12. allneededpharmacy.com,
  13. allrxsales.net,
  14. americantrustpills.com,
  15. asianpharmacy.com,
  16. best-online-ed-store.com,
  17. best-preparation-online.com,
  18. bestcureshop.com,
  19. bestdrugsstocks.com,
  20. bestgenericssupplier.com,
  21. buytabshere.com,
  22. canada247rx.com,
  23. canadian-medsonline.net,
  24. central-rx-refill.com,
  25. drug-24.com,
  26. drugstore-24h.com,
  27. ecarepharmacy.com,
  28. edeuro.com,
  29. edeuropeangenerics.com,
  30. edpharmacy.net,
  31. elifepharmacy.com,
  32. eliferx.com,
  33. epharm4u.com,
  34. eumedportal.com,
  35. euro-shoppy.com,
  36. euromeds.net,
  37. europillz.com,
  38. excelpharmacy.com,
  39. expresstabs.com,
  40. ezmedsbiz.com,
  41. first-meds.com,
  42. generic-sales.com,
  43. generic4.com,
  44. generika1.com,
  45. globaldiscountpills.com,
  46. globalrxdeals.com,
  47. globalrxorders.com,
  48. goget-pills.com,
  49. gold-rx.com,
  50. horizondrugs.com,
  51. indianonlinepharmacy.com,
  52. instant-online-refills.com,
  53. instant-online-solution.com,
  54. kamagra-uk.net,
  55. kamagraerektion.com,
  56. leading-pharmacy.net,
  57. legalmedsonline.com,
  58. med-shop-24.com,
  59. med-support-online.com,
  60. medsforall.net,
  61. medspills.com,
  62. megarxdeals.com,
  63. megarxonline.net,
  64. multi-pharmacie.com,
  65. my-health-24.com,
  66. my-web-pills.com,
  67. mypillmarket.com,
  68. online-indianpharmacy.com,
  69. online-medz.com,
  70. online-pharmacy-24h.com,
  71. onlinecanadianpharmacy24.com,
  72. overnightforus.com,
  73. oxspharmacy.com,
  74. perfect-edstore.com,
  75. perfect-onlinepharmacy.com,
  76. pharmacieleschamps.com,
  77. pharmacyglobalrx.com,
  78. pill4u.net,
  79. pillorders.net,
  80. pillsforyou24.com,
  81. pillsm.com,
  82. pillsstock.com,
  83. popular-pillsonline.com,
  84. popularedproducts.com,
  85. popularpills-online.com,
  86. power-pillsed.com,
  87. premium-pharmacy.com,
  88. premiumcharge.net,
  89. premiumrxpills.com,
  90. prescriptionspoint.com,
  91. prioritypharmacy.com,
  92. priorpharmacy.com,
  93. procanadadrugs.com,
  94. realhealthcenter.com,
  95. reliable-med-supplier.com,
  96. rx-911.com,
  97. rxbuys.com,
  98. rxdaily.com,
  99. rxeurope.com,
  100. rxmegastore.com,
  101. rxnordic.com,
  102. rxpillsmd.com,
  103. rxshoppers.net,
  104. safe-ed-pills.com,
  105. safedrugstock.com,
  106. safepillsstock.com,
  107. search-drugs.com,
  108. searchpharmacy.com,
  109. secure-canadian-pharmacy.com,
  110. securepillshop24.com,
  111. sgpharm.net,
  112. shop4pills.net,
  113. shoprxtoday.com,
  114. stockmeds.com,
  115. thesecuretabs.com,
  116. top-drugstore.com,
  117. topindiangenerics.com,
  118. toppillen.net,
  119. trusted-tablets.com,
  120. trusted-tabs.com,
  121. trustedonline.net,
  122. trustedsafepharmacy.com,
  123. trustedtabspharmacy.com,
  124. trustrx.net,
  125. trusty-pharmacy.com,
  126. trustymed.com,
  127. uniquestore4ed.com,
  128. united-pharmacies.com,
  129. universalonlinepharmacy.com,
  130. usagenerics.com,
  131. usonline-rx.net,
  132. usonlinerx.com,
  133. usrxonline.net,
  134. v-medical.net,
  135. viagraonlinepharmacy.com,
  136. viking-sun.com,
  137. webpharmastore.com,
  138. worldbestonlinepharmacy.com,
  139. worldpharmcare.com,
  140. worlds-bestpharmacy.com,
  141. xl-pharmacy.com
  142. your-excellent-tablets.com,
  143. yourtrustpillsupplier.com,
  144. yourtrustprescriptionsupplier.com

109.236.81.241 resolves to server.d-na.net.

The following A records are set to 109.236.81.241:

  1. ns2.morpheusdns.com
  2. onlypharmacypills.com
  3. onlyrxmeds.com
  4. onlyrxpills.com

Address lookup

canonical name:onlyrxmeds.com
aliases http://www.onlyrxmeds.com
addresses :109.236.81.241
Domain Whois record

Queried whois.internic.net with “dom onlyrxmeds.com”…

Domain Name: ONLYRXMEDS.COM
Registry Domain ID: 2067570877_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.r01.ru
Registrar URL: http://r01.ru
Updated Date: 2017-09-26T10:09:55Z
Creation Date: 2016-10-20T15:24:50Z

Registry Expiry Date: 2018-10-20T15:24:50Z
Registrar: JSC Registrar R01
Registrar IANA ID: 1426
Registrar Abuse Contact Email: tld-abuse@r01.ru
Registrar Abuse Contact Phone: +7(495) 783-3-783
Domain Status: clientTransferProhibited

Name Server: NS1.MORPHEUSDNS.COM
Name Server: NS2.MORPHEUSDNS.COM

DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:

>>> Last update of whois database: 2017-10-15T04:05:50Z <<<
Queried whois.r01.ru with "onlyrxmeds.com"…

Domain Name: ONLYRXMEDS.COM
Registry Domain ID: 2067570877_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.r01.ru
Registrar URL: http://www.r01.ru
Updated Date: 2017-09-26T13:10:37+03:00
Creation Date: 2016-10-20T18:24:50+03:00
Registrar Registration Expiration Date: 2018-10-20T18:24:50+03:00
Registrar: CJSC REGISTRAR R01
Registrar IANA ID: 1426
Registrar Abuse Contact Email: tld-abuse@r01.ru
Registrar Abuse Contact Phone: +7.4957833783
Reseller:
Domain Status: clientTransferProhibited

Registry Registrant ID:
Registrant Name: Privacy protection service – r01.whoisproxy.ru.
Registrant Organization: Privacy protection service – r01.whoisproxy.ru.
Registrant Street: PO box 99, whoisproxy.ru
Registrant City: Moscow
Registrant State/Province: Moscow region
Registrant Postal Code: 123308
Registrant Country: RU
Registrant Phone: +7.4957856536
Registrant Email: onlyrxmeds.com@r01.whoisproxy.ru

Registry Admin ID:
Admin Name: Privacy protection service – r01.whoisproxy.ru.
Admin Organization: Privacy protection service – r01.whoisproxy.ru.
Admin Street: PO box 99, whoisproxy.ru
Admin City: Moscow
Admin State/Province: Moscow region
Admin Postal Code: 123308
Admin Country: RU
Admin Phone: +7.4957856536
Admin Email: onlyrxmeds.com@r01.whoisproxy.ru

Registry Tech ID:
Tech Name: Privacy protection service – r01.whoisproxy.ru.
Tech Organization: Privacy protection service – r01.whoisproxy.ru.
Tech Street: PO box 99, whoisproxy.ru
Tech City: Moscow
Tech State/Province: Moscow region
Tech Postal Code: 123308
Tech Country: RU
Tech Phone: +7.4957856536
Tech Email: onlyrxmeds.com@r01.whoisproxy.ru

Name Server: ns1.morpheusdns.com
Name Server: ns2.morpheusdns.com

DNSSEC: Unsigned
URL of the ICANN WHOIS Data Problem Reporting System:

Last update of WHOIS database: 2017-10-15T07:06:07+03

Network Whois record

Queried whois.ripe.net with "-B 109.236.81.241"…
Information related to '109.236.81.0 – 109.236.81.255'
Abuse contact for '109.236.81.0 – 109.236.81.255'

inetnum: 109.236.81.0 – 109.236.81.255
netname: WORLDSTREAM
descr: WorldStream IPv4.24
country: NL
admin-c: WS1670-RIPE
tech-c: WS1670-RIPE
status: ASSIGNED PA
remarks: INFRA-AW
mnt-by: MNT-WORLDSTREAM
created: 2010-05-11T11:46:45Z
last-modified: 2012-09-13T12:34:00Z
source: RIPE

role: WORLDSTREAM DBM
address: Industriestraat 24
address: 2671CT NAALDWIJK
address: The Netherlands
phone: +31174712117
e-mail: info@worldstream.nl
abuse-mailbox: abuse@worldstream.nl
admin-c: DV1495-RIPE
tech-c: DV1495-RIPE
nic-hdl: WS1670-RIPE
mnt-by: MNT-WORLDSTREAM
created: 2008-05-15T09:52:38Z
last-modified: 2013-08-20T11:17:59Z
source: RIPE

% Information related to '109.236.80.0/20AS49981'

route: 109.236.80.0/20
descr: WORLDSTREAM-BLK-109.236.80.0
origin: AS49981
remarks: ————————————————
remarks: Abuse notifications to: abuse@worldstream.nl
remarks: ————————————————
mnt-by: MNT-WORLDSTREAM
created: 2009-12-09T17:14:22Z
last-modified: 2011-11-01T12:07:56Z
source: RIPE

% This query was served by the RIPE Database Query Service version 1.89.2 (BLAARKOP)

WhoIs mynextdoorpharmsnow.com

Drug Enforcement Agency

United States of America

The Ryan Haight Act Known as
Online Pharmacy Consumer Protection Act of 2008
Sec. 2. Requirement of a valid prescription for
controlled substances dispensed by means of the Internet.

Who’s Behind These Online Pharmacies

SUMMARY: The Ryan Haight Online Pharmacy Consumer Protection Act,
which was enacted on October 15, 2008,amended the Controlled Substances Act and Controlled Substances Import and Export Act by adding several new provisions to prevent the illegal distribution and dispensing of controlled substances by means of the Internet.
_________________________________


Purchase All Your Favorite RxMedications Online!..No Prescription Needed!
Browse_Our Selection_Today! -> http://hardtofindrxmedznow.com

bluebridrx


Domain
  1. activens65.com
  2. greattrustedrxcity.com
  3. mytrustedrxsale.com
  4. mynewrxworld.com
  5. myfastrxmed.com
  6. besttrustedrxavenue.com
  7. besttrustedrxdepot.com
  8. greattrustedrxplace.com
  9. besttrustedrxzone.com
  10. myrxcarenow.com
  11. besttrustedrxnation.com
  12. besttrustedrxstation.com
  13. greattrustedrxrefills.com
  14. myeasyrxnow.com
  15. greattrustedrxworld.com
  16. mylpmeds.com
  17. securerefillrxoutletnow.com
  18. securerefillrxplanetnow.com
  19. securerefillrxspecialsnow.com
  20. mynycpharmnow.com
  21. securerefillrxsuperstorenow.com
  22. securerefillrxcitynow.com
  23. securerefillrxuniversenow.com
  24. securerefillrxvillenow.com
  25. myrxworldtoonow.com
  26. mytherxhomenow.com
  27. mybkpharmnow.com
  28. myrxshieldnow.com
  29. securerefillrxmarketnow.com
  30. securerefillrxbuynow.com
  31. securerefillrxshopnow.com
  32. refillrxzone.com
  33. refillrxdepot.com
  34. refillrxworld.com
  35. refillrxplanet.com
  36. refillrxstation.com
  37. refillrxoutlet.com
  38. refillrxstore.com
  39. refillrxsuperstore.com
  40. savegoody.com
  41. publicgoody.com
  42. raiseyearly.com
  43. yearlyweb.com
  44. uptowngoody.com
  45. refillrxcity.com
  46. refillrxuniverse.com
  47. alibahostnow.com
  48. myrefillrxclub.com
  49. myrefillrxmarket.com
  50. myrefillrxwarehouse.com
  51. myrefillrxville.com
  52. myrefillrxbuy.com
  53. myrefillrxplace.com
  54. myrefillrxnet.com
  55. myrefillrxspecials.com
  56. myrefillrxweb.com
  57. myrefillrxshop.com
  58. verygoodrxonline.com
  59. great2nss.com
  60. rxtopsellers.com
  61. manyrxmeds.com
  62. membersmeds.com
  63. ustopmeds.com
  64. verygoodrx.com
  65. greatdeal2009today.com
  66. myverygoodrx.com
  67. verygoodrxtoday.com
  68. hothost44.com
  69. mosthighlysoughtafter.com
  70. secretstashe.com
  71. wehavethemforyou.com
  72. goodzchoices.com
  73. honorablechoice.com
  74. kingofthekingofrxznow.com
  75. greatestofrxznow.com
  76. findallthebestherenow.com
  77. blowingawaytherestnow.com
  78. uniqueflowagesnow.com
  79. flowagerofgood.com
  80. theflowageoccurshere.com
  81. reliableflowagehere.com
  82. meddiezcenter.com
  83. happeninggoodtime.com
  84. bestelitepharmas.com
  85. abcpharmasupply.com
  86. ilike34ns.com
  87. gopharmas.com
  88. elitepharmas.com
  89. bestpharmas.com
  90. harfindpharmas.com
  91. hardtogetpharms.com
  92. xyzpharms.com
  93. bestpricespharms.com
  94. findhardtogetmedz.com
  95. mymallmegapharms.com
  96. mybestaroundpharms.com
  97. mypharmsnextday.com
  98. myfastdelivpharms.com
  99. mymegamallpharms.com
  100. mynextdoorpharmsnow.com
  101. mybestdelivpharms.com
  102. mymegadelivpharms.com
  103. myrx4lesspharms.com
  104. mydoitallpharms.com
  105. rxsaleuniverse.com
  106. rxzonerefills.com
  107. lololohg3.com
  108. rxwebrefills.com
  109. rxrefillplanet.com
  110. rxdepotsale.com
  111. refillrxpalace.com
  112. rxrefillnation.com
  113. fastrefillsweb.com
  114. refillplanetweb.com
  115. rxsuperstores.com
  116. rxnetrefills.com

Domain active

  1. 65.comgreattrustedrxcity.com
  2. mytrustedrxsale.com
  3. mynewrxworld.com
  4. myfastrxmed.com
  5. besttrustedrxavenue.com
  6. besttrustedrxdepot.com
  7. greattrustedrxplace.com
  8. besttrustedrxzone.com
  9. myrxcarenow.com
  10. besttrustedrxnation.com
  11. besttrustedrxstation.com
  12. greattrustedrxrefills.com
  13. myeasyrxnow.com
  14. greattrustedrxworld.com
  15. mylpmeds.com
  16. securerefillrxoutletnow.com
  17. securerefillrxplanetnow.com
  18. securerefillrxspecialsnow.com
  19. mynycpharmnow.com
  20. securerefillrxsuperstorenow.com
  21. securerefillrxcitynow.com
  22. securerefillrxuniversenow.com
  23. securerefillrxvillenow.com
  24. myrxworldtoonow.com
  25. mytherxhomenow.com
  26. mybkpharmnow.com
  27. myrxshieldnow.com
  28. securerefillrxmarketnow.com
  29. securerefillrxbuynow.com
  30. securerefillrxshopnow.com
  31. refillrxzone.comrefillrxdepot.com
  32. refillrxworld.comrefillrxplanet.com
  33. refillrxstation.com
  34. refillrxoutlet.com
  35. refillrxstore.com
  36. refillrxsuperstore.com
  37. savegoody.com
  38. publicgoody.com
  39. raiseyearly.com
  40. yearlyweb.com
  41. uptowngoody.com
  42. refillrxcity.com
  43. refillrxuniverse.com
  44. alibahostnow.com
  45. myrefillrxclub.com
  46. myrefillrxmarket.com
  47. myrefillrxwarehouse.com
  48. myrefillrxville.com
  49. myrefillrxbuy.com
  50. myrefillrxplace.com
  51. myrefillrxnet.com
  52. myrefillrxspecials.com
  53. myrefillrxweb.com
  54. myrefillrxshop.com
  55. verygoodrxonline.com
  56. great2nss.comrxtopsellers.com
  57. manyrxmeds.com
  58. membersmeds.com
  59. ustopmeds.com
  60. verygoodrx.com
  61. greatdeal2009today.com
  62. myverygoodrx.com
  63. verygoodrxtoday.com
  64. hothost44.com
  65. mosthighlysoughtafter.com
  66. secretstashe.com
  67. wehavethemforyou.com
  68. goodzchoices.com
  69. honorablechoice.com
  70. kingofthekingofrxznow.com
  71. greatestofrxznow.com
  72. findallthebestherenow.com
  73. blowingawaytherestnow.com
  74. uniqueflowagesnow.com
  75. flowagerofgood.com
  76. theflowageoccurshere.com
  77. reliableflowagehere.com
  78. meddiezcenter.com
  79. happeninggoodtime.com
  80. bestelitepharmas.com
  81. abcpharmasupply.com
  82. ilike34ns.comgopharmas.com
  83. elitepharmas.com
  84. bestpharmas.com
  85. harfindpharmas.com
  86. hardtogetpharms.com
  87. xyzpharms.com
  88. bestpricespharms.com
  89. findhardtogetmedz.com
  90. mymallmegapharms.com
  91. mybestaroundpharms.com
  92. mypharmsnextday.com
  93. myfastdelivpharms.com
  94. mymegamallpharms.com
  95. mynextdoorpharmsnow.com
  96. mybestdelivpharms.com
  97. mymegadelivpharms.com
  98. myrx4lesspharms.com
  99. mydoitallpharms.com
  100. rxsaleuniverse.com
  101. rxzonerefills.com
  102. lololohg3.com
  103. rxwebrefills.com
  104. rxrefillplanet.com
  105. rxdepotsale.com
  106. refillrxpalace.com
  107. rxrefillnation.com
  108. fastrefillsweb.com
  109. refillplanetweb.com
  110. rxsuperstores.com
  111. rxnetrefills.com

Address lookup

canonical name hardtofindrxmedznow.com.
aliases
addresses 222.170.127.122

Domain Whois record

Queried whois.internic.net with “dom hardtofindrxmedznow.com”…

   Domain Name: HARDTOFINDRXMEDZNOW.COM
   Registrar: CHINA SPRINGBOARD INC.
   Whois Server: whois.namerich.cn
   Referral URL: http://www.namerich.cn
   Name Server: NS1.91UKRAINE.COM
   Name Server: NS2.91UKRAINE.COM
   Name Server: NS3.LIKENS45.COM
   Name Server: NS4.LIKENS45.COM
   Name Server: NS5.ANTRASCRNS.COM
   Name Server: NS6.ANTRASCRNS.COM
   Status: clientDeleteProhibited
   Status: clientTransferProhibited
   Updated Date: 01-nov-2009
   Creation Date: 30-sep-2009
   Expiration Date: 30-sep-2010

Last update of whois database: Tue, 10 Nov 2009 08:06:16 UTC <<<

Queried whois.namerich.cn with “hardtofindrxmedznow.com”…

 DomainName : hardtofindrxmedznow.com

RSP: China Springboard Inc.
URL: http://www.namerich.cn      

Name Server......................NS2.91UKRAINE.COM
Name Server......................NS4.LIKENS45.COM
Name Server......................NS5.ANTRASCRNS.COM
Name Server......................NS1.91UKRAINE.COM
Name Server......................NS6.ANTRASCRNS.COM
Name Server......................NS3.LIKENS45.COM
Status...........................clientTransferProhibited
Status...........................clientDeleteProhibited
Creation  Date ..................2009-10-01
Expiration Date .................2010-10-01
Last Update  Date ...............2009-11-02

Registrant ID ...................V-X-63774-22022
Registrant Name .................LIN YIXIA
Registrant Organization .........LINYIXIA
Registrant Address ..............chongjiangxilu42
Registrant City..................JN
Registrant Province/State .......ShanDong
Registrant Country Code .........CN
Registrant Postal Code ..........250069
Registrant Phone Number .........+86.053181416841
Registrant Fax ..................+86.053181416841
Registrant Email ................kuledeliu@126.com

Administrative ID ...............V-X-63774-22022
Administrative Name .............LIN YIXIA
Administrative Organization .....LINYIXIA
Administrative Address ..........chongjiangxilu42
Administrative City..............JN
Administrative Province/State ...ShanDong
Administrative Country Code .....CN
Administrative Postal Code ......250069
Administrative Phone Number .....+86.053181416841
Administrative Fax ..............+86.053181416841
Administrative Email ............kuledeliu@126.com

Billing ID ......................V-X-63774-22022
Billing Name ....................LIN YIXIA
Billing Organization ............LINYIXIA
Billing Address .................chongjiangxilu42
Billing City.....................JN
Billing Province/State ..........ShanDong
Billing Country Code ............CN
Billing Postal Code .............250069
Billing Phone Number ............+86.053181416841
Billing Fax .....................+86.053181416841
Billing Email ...................kuledeliu@126.com

Technical ID ....................V-X-63774-22022
Technical Name ..................LIN YIXIA
Technical Organization...........LINYIXIA
Technical Address ...............chongjiangxilu42
Technical City...................JN
Technical Province/State.........ShanDong
Technical Country Code ..........CN
Technical Postal Code ...........250069
Technical Phone Number ..........+86.053181416841
Technical Fax ...................+86.053181416841
Technical Email .................kuledeliu@126.com

; Please register your domains at
; http://www.namerich.cn

Network Whois record

Queried whois.apnic.net with “222.170.127.122”…

inetnum:      222.170.0.0 - 222.172.127.255
netname:      CHINANET-HL
descr:        CHINANET HEILONGJIANG PROVINCE NETWORK
descr:        Heilongjiang Telecom Corporation
descr:        NO.178 Zhongshan Road,Haerbin,Heilongjiang 150040
country:      CN
admin-c:      LZ298-AP
tech-c:       CH93-AP
mnt-by:       APNIC-HM
mnt-lower:    MAINT-CHINANET-HL
mnt-routes:   MAINT-CHINANET-HL
remarks:      -+-+-+-+-+-+-+-+-+-+-+-++-+-+-+-+-+-+-+-+-+-+-+-+-+-+
remarks:      This object can only be updated by APNIC hostmasters.
remarks:      To update this object, please contact APNIC
remarks:      hostmasters and include your organisation's account
remarks:      name in the subject line.
remarks:      -+-+-+-+-+-+-+-+-+-+-+-++-+-+-+-+-+-+-+-+-+-+-+-+-+-+
status:       ALLOCATED PORTABLE
changed:      hm-changed@apnic.net 20040305
changed:      hm-changed@apnic.net 20060605
source:       APNIC

person:       LIJUAN ZHENG
nic-hdl:      LZ298-AP
e-mail:       network@hljtele.com
address:      Communication Corporation Internet Enterprise Division of HLJ
phone:        +86-451-53902002
fax-no:       +86-451-53900012
country:      CN
changed:      jxwx1234@163.com 20061229
mnt-by:       MAINT-CHINANET-HLJTELE
source:       APNIC

person:       Chinanet Hostmaster
nic-hdl:      CH93-AP
e-mail:       anti-spam@ns.chinanet.cn.net
address:      No.31 ,jingrong street,beijing
address:      100032
phone:        +86-10-58501724
fax-no:       +86-10-58501724
country:      CN
changed:      dingsy@cndata.com 20070416
mnt-by:       MAINT-CHINANET
source:       APNIC

DNS records

DNS query for 122.127.170.222.in-addr.arpa returned an error from the server: NameError

name class type data time to live
hardtofindrxmedznow.com IN SOA
server: ns.hardtofindrxmedznow.com
email: admin.hardtofindrxmedznow.com
serial: 2009100101
refresh: 300
retry: 300
expire: 14400
minimum ttl: 300
300s (00:05:00)
hardtofindrxmedznow.com IN A 222.170.127.122 300s (00:05:00)

— end —

Global Pharmacy Plus ~ globalpharmacyplus.com

Drug Enforcement Agency

United States of America

The Ryan Haight Act Known as
Online Pharmacy Consumer Protection Act of 2008
Sec. 2. Requirement of a valid prescription for
controlled substances dispensed by means of the Internet.

Who’s Behind These Online Pharmacies

SUMMARY: The Ryan Haight Online Pharmacy Consumer Protection Act,
which was enacted on October 15, 2008,amended the Controlled Substances Act and Controlled Substances Import and Export Act by adding several new provisions to prevent the illegal distribution and dispensing of controlled substances by means of the Internet.
_________________________________

GlobalPharmacyPlus.png
The following A records are set to 66.212.239.209

  1. globalmedicalplus.com
  2. globalpharmacycanada.com
  3. globalpharmacyplus.com
  4. gpihealth.com

Address lookup
canonical name:globalpharmacyplus.com

aliases:globalpharmacyplus.com
addresses:66.212.239.209
Domain Whois record

Queried whois.internic.net with “dom globalpharmacyplus.com”…

Domain Name: GLOBALPHARMACYPLUS.COM
Registry Domain ID: 1762072025_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.regtons.com
Registrar URL: http://subreg.cz
Updated Date: 2016-09-09T18:37:14Z
Creation Date: 2012-11-26T22:01:04Z
Registry Expiry Date: 2017-11-26T22:01:04Z
Registrar: Gransy s.r.o d/b/a subreg.cz
Registrar IANA ID: 1505
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: ok

Name Server: NS.GRANSY.COM
Name Server: NS2.GRANSY.COM
Name Server: NS3.GRANSY.COM
Name Server: NS4.GRANSY.COM
Name Server: NS5.GRANSY.COM

DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint
Last update of whois database: 2017-10-14T15:17:36Z
Queried whois.regtons.com with “globalpharmacyplus.com”…

Domain Name: globalpharmacyplus.com
Registry Domain ID: 1762072025_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.regtons.com
Registrar URL: http://regtons.com
Updated Date: 2016-09-09T00:00:00Z
Creation Date: 2012-11-26T00:00:00Z
Registrar Registration Expiration Date: 2017-11-26T00:00:00Z
Registrar: GRANSY S.R.O D/B/A SUBREG.CZ
Registrar IANA ID: 1505
Registrar Abuse Contact Email: abuse@regtons.com
Registrar Abuse Contact Phone: +420.734463373
Reseller:
Domain Status: ok

Registry Registrant ID: PRIVACY_PROTECTION
Registrant Name: Domain Admin
Registrant Organization: Whois protection, this company does not own this domain name s.r.o.
Registrant Street: Jaurisova 515/4
Registrant City: Praha 4
Registrant State/Province:
Registrant Postal Code: 14000
Registrant Country: CZ
Registrant Phone: +420.226517351
Registrant Fax: +420.226517341
Registrant Email: globalpharmacyplus.com@fablovkawhoisprotection.com

Registry Admin ID: PRIVACY_PROTECTION
Admin Name: Domain Admin
Admin Organization: Whois protection, this company does not own this domain name s.r.o.
Admin Street: Jaurisova 515/4
Admin City: Praha 4
Admin State/Province:
Admin Postal Code: 14000
Admin Country: CZ
Admin Phone: +420.226517351
Admin Fax: +420.226517341
Admin Email: globalpharmacyplus.com@fablovkawhoisprotection.com

Registry Tech ID: PRIVACY_PROTECTION
Tech Name: Domain Admin
Tech Organization: Whois protection, this company does not own this domain name s.r.o.
Tech Street: Jaurisova 515/4
Tech City: Praha 4
Tech State/Province:
Tech Postal Code: 14000
Tech Country: CZ
Tech Phone: +420.226517351
Tech Fax: +420.226517341
Tech Email: globalpharmacyplus.com@fablovkawhoisprotection.com

Name Server: ns.gransy.com
Name Server: ns2.gransy.com
Name Server: ns3.gransy.com
Name Server: ns4.gransy.com
Name Server: ns5.gransy.com

DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System:

Last update of WHOIS database: 2017-10-14T15:00:00Z
Network Whois record

Queried whois.arin.net with “n ! NET-66-212-239-208-1″…

NetRange: 66.212.239.208 – 66.212.239.215
CIDR: 66.212.239.208/29
NetName: MIT-FARMA-2
NetHandle: NET-66-212-239-208-1
Parent: CL-1379 (NET-66-212-224-0-1)
NetType: Reassigned
OriginAS: AS14537
Organization: Global Pharmacy Canada Inc (GLOBA-386)
RegDate: 2011-08-08
Updated: 2011-08-08
Ref: https://whois.arin.net/rest/net/NET-66-212-239-208-1

OrgName: Global Pharmacy Canada Inc
OrgId: GLOBA-386
Address: 16 Albert Hoy Avenue, Suite 1053
City: Belize City
StateProv:
PostalCode:
Country: BZ
RegDate: 2010-10-05
Updated: 2011-09-24
Ref: https://whois.arin.net/rest/org/GLOBA-386

OrgAbuseHandle: SYSTE328-ARIN
OrgAbuseName: System Administrator
OrgAbusePhone: 555-555-5555
OrgAbuseEmail: questions@globalpharmacycanada.com
OrgAbuseRef: https://whois.arin.net/rest/poc/SYSTE328-ARIN

OrgTechHandle: SYSTE328-ARIN
OrgTechName: System Administrator
OrgTechPhone: 555-555-5555
OrgTechEmail: questions@globalpharmacycanada.com
OrgTechRef: https://whois.arin.net/rest/poc/SYSTE328-ARIN

WhoIs Pharmacy RX One ~ pharmacy-rx-one.com

Drug Enforcement Agency

United States of America

The Ryan Haight Act Known as
Online Pharmacy Consumer Protection Act of 2008
Sec. 2. Requirement of a valid prescription for
controlled substances dispensed by means of the Internet.

Who’s Behind These Online Pharmacies

SUMMARY: The Ryan Haight Online Pharmacy Consumer Protection Act,
which was enacted on October 15, 2008,amended the Controlled Substances Act and Controlled Substances Import and Export Act by adding several new provisions to prevent the illegal distribution and dispensing of controlled substances by means of the Internet.
_________________________________

pharmacyRxOne

pharmacyRxOne_server

187.45.187.130 resolves to s1-saopaulo.accountservergroup.com.

The following A records are set to 187.45.187.130:

  1. hunterswalkcommunity.com
  2. omelhorbet.com
  3. pianobrasileiro.com
  4. preventisnutrition.com
  5. smartcelulares.com
  6. vamikos.com
  7. welimen.com
  8. ziloex.com

Address lookup
canonical name:pharmacy-rx-one.com
aliases
addresses: 185.173.26.47
Domain Whois record

Queried whois.internic.net with “dom pharmacy-rx-one.com

Domain Name: PHARMACY-RX-ONE.COM
Registry Domain ID: 1823611417_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.registrar.eu
Registrar URL: http://www.openprovider.com
Updated Date: 2017-05-12T11:52:42Z
Creation Date: 2013-08-26T09:23:43Z
Registry Expiry Date: 2019-08-26T09:23:43Z

Registrar: Hosting Concepts B.V. d/b/a Openprovider
Registrar IANA ID: 1647
Registrar Abuse Contact Email: abuse@registrar.eu
Registrar Abuse Contact Phone: +31.104482297
Domain Status: ok

Name Server: NS1.HAMSTER.HOST1PLUS.COM
Name Server: NS2.HAMSTER.HOST1PLUS.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form:

Last update of whois database: 2017-10-14T14:52:56Z
Queried whois.registrar.eu with “pharmacy-rx-one.com”…

Domain Name: pharmacy-rx-one.com
Registry Domain ID:
Registrar WHOIS Server: whois.registrar.eu
Registrar URL: http://www.registrar.eu
Updated Date: 2017-05-12T13:52:43Z
Creation Date: 2013-08-26T09:23:43Z
Registrar Registration Expiration Date: 2019-08-26T09:23:43Z

Registrar: Hosting Concepts B.V. d/b/a Openprovider
Registrar IANA ID: 1647
Registrar Abuse Contact Email: abuse@registrar.eu
Registrar Abuse Contact Phone: +31.104482297
Domain Status: ok https:

Registry Registrant ID: WF903118-NL
Registrant Name: Whois Privacy Protection Foundation
Registrant Organization: Whois Privacy Protection Foundation
Registrant Street: Willem Buytewechstraat 40
Registrant City: Rotterdam
Registrant State/Province: Zuid-Holland
Registrant Postal Code: 3024 BN
Registrant Country: NL
Registrant Phone: +31.104482295
Registrant Email: info@privacyprotected.domains

Registry Admin ID: WF903118-NL
Admin Name: Whois Privacy Protection Foundation
Admin Organization: Whois Privacy Protection Foundation
Admin Street: Willem Buytewechstraat 40
Admin City: Rotterdam
Admin State/Province: Zuid-Holland
Admin Postal Code: 3024 BN
Admin Country: NL
Admin Phone: +31.104482295
Admin Email: info@privacyprotected.domains

Registry Tech ID: WF903118-NL
Tech Name: Whois Privacy Protection Foundation
Tech Organization: Whois Privacy Protection Foundation
Tech Street: Willem Buytewechstraat 40
Tech City: Rotterdam
Tech State/Province: Zuid-Holland
Tech Postal Code: 3024 BN
Tech Country: NL
Tech Phone: +31.104482295
Tech Email: info@privacyprotected.domains

Name Server: ns1.hamster.host1plus.com
Name Server: ns2.hamster.host1plus.com

DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System:

Last update of WHOIS database: 2017-10-14T14:53:09Z
Network Whois record

Queried whois.ripe.net with “-B 185.173.26.47″…

Information related to ‘185.173.24.0 – 185.173.27.255’
Abuse contact for ‘185.173.24.0 – 185.173.27.255’ is ‘abuse@host1plus.com’

inetnum: 185.173.24.0 – 185.173.27.255
netname: UK-CAMPUSBLACK-20161014
country: DE
org: ORG-CBL10-RIPE
admin-c: DS19388-RIPE
tech-c: DS19388-RIPE
status: ALLOCATED PA
mnt-by: RIPE-NCC-HM-MNT
mnt-by: uk-campusblack-1-mnt
created: 2016-10-14T10:18:17Z
last-modified: 2016-10-14T10:18:17Z
source: RIPE

organisation: ORG-CBL10-RIPE
org-name: Campus Black Limited
org-type: LIR
address: Dalton House, 60 Windsor Avenue
address: SW19 2RR
address: London
address: UNITED KINGDOM
e-mail: ripe@campusblack.com
admin-c: DS19388-RIPE
tech-c: DS19388-RIPE
abuse-c: AR37937-RIPE
mnt-ref: uk-campusblack-1-mnt
mnt-by: RIPE-NCC-HM-MNT
mnt-by: uk-campusblack-1-mnt
created: 2016-10-13T07:00:37Z
last-modified: 2017-03-23T08:05:13Z
source: RIPE
phone: +4408708200222

person: Dovile Sukiene
address: Dalton House, 60 Windsor Avenue
address: SW19 2RR
address: London
address: UNITED KINGDOM
phone: +442081233556
nic-hdl: DS19388-RIPE
mnt-by: uk-campusblack-1-mnt
created: 2016-10-13T07:00:37Z
last-modified: 2016-10-13T07:00:37Z
source: RIPE

% Information related to ‘185.173.26.0/24AS61317’

route: 185.173.26.0/24
descr: Digital Energy Technologies Limited
origin: AS61317
mnt-by: uk-campusblack-1-mnt
created: 2017-01-10T11:15:28Z
last-modified: 2017-01-10T11:15:28Z
source: RIPE

% This query was served by the RIPE Database Query Service version 1.89.2 (HEREFORD)
DNS records

name class type data time to live
pharmacy-rx-one.com IN A 185.173.26.47 14400s (04:00:00)
pharmacy-rx-one.com IN NS ns1.hamster.host1plus.com 86400s (1.00:00:00)
pharmacy-rx-one.com IN NS ns2.hamster.host1plus.com 86400s (1.00:00:00)
pharmacy-rx-one.com IN SOA
server: ns1.hamster.host1plus.com
email: support@host1plus.com
serial: 2017051206
refresh: 3600
retry: 7200
expire: 1209600
minimum ttl: 86400
86400s (1.00:00:00)
pharmacy-rx-one.com IN MX
preference: 10
exchange: mail.pharmacy-rx-one.com
14400s (04:00:00)
pharmacy-rx-one.com IN TXT v=spf1 a mx ip4:185.34.40.2 ~all 14400s (04:00:00)
47.26.173.185.in-addr.arpa IN PTR hamster.haphost.com 86400s (1.00:00:00)
26.173.185.in-addr.arpa IN NS ns10.host1plus.com 86400s (1.00:00:00)
26.173.185.in-addr.arpa IN NS ns9.host1plus.com 86400s (1.00:00:00)
26.173.185.in-addr.arpa IN NS ns8.host1plus.com 86400s (1.00:00:00)
26.173.185.in-addr.arpa IN SOA
server: ns8.host1plus.com
email: postmaster@ns8.host1plus.com
serial: 2017101401
refresh: 28800
retry: 7200
expire: 2419200
minimum ttl: 86400
86400s (1.00:00:00)
— end —
URL for this output | return to CentralOps.net, a service of Hexillion

EDonline – Pharmacy Drop Shipping Service

Name: edonline
Email: edonlinepharmacy@gmail.com
Website:

Comment: Hello Sir:
Greeting of the day! I hope you are doing well.
We are among the leading service providers, making available Pharmacy Drop Shipping Service for our esteemed customers. Through these services, we serve as logistics partners for our customers, processing the orders placed on their e-commerce websites.

Our services are carried out in a highly cost-effective manner with no middlemen involved in the delivery process. Our vast cargo shipping network covers all major routes across the world.

Features:

• • Cost-effective
• • No middlemen involved
• • Vast distribution network

Here are just some of the benefits your business can experience by using our service to drop ship products directly to your customers:

• Your customer gets best quality of medicine
• We are supplying more than 3000 quality products at cheapest rates
• Lowest drop ship rates covering major countries
• No middleman, Drop Shipping is done directly by Us
• Medicines are packed discreetly
• Free Reshipment if not reached destination
• No Minimum Quantity limit
• Live professional assistance available 24/7
• All data stored in Safe and Virus free Offshore Server
• You showcase Medicine on your website along with your retail price
• Buyers come to your website and buy medicine showcased on your website
• Buyer pays to you at your retail price via Credit card
• You forward this orders to edonlinepharmacy@gmail.com and remember you pay to us at wholesale price only, so difference between retail price and Wholesale price is your Net Profit
• We discreetly pack in Box and deliver the Medicine to your customer anywhere in world of course, where it all is permitted & practical.

Email id: edonlinepharmacy@gmail.com
Skype id: edonlinepharmacy
Phone no:- 825-074-4959

WhoIs PharmEmpire?

Drug Enforcement Agency

United States of America

The Ryan Haight Act Known as
Online Pharmacy Consumer Protection Act of 2008
Sec. 2. Requirement of a valid prescription for
controlled substances dispensed by means of the Internet.

Who’s Behind These Online Pharmacies

SUMMARY: The Ryan Haight Online Pharmacy Consumer Protection Act,
which was enacted on October 15, 2008,amended the Controlled Substances Act and Controlled Substances Import and Export Act by adding several new provisions to prevent the illegal distribution and dispensing of controlled substances by means of the Internet.
_________________________________

PharmaEmpire.png
 
global pharmacy plus coupon
global pharmacy canada viagra
global pharmacy viagra
global pharmacy plus legal
gpharmaplus
global pharmacy plus reviews
global pharmacy phone number
global pharmacy cialis

The following A records are set to 213.239.221.171:
ns1.pharmempire.com
ns1.spambucks.com


Address lookup

canonical name :pharmempire.com
aliases
addresses :213.239.221.171
Domain Whois record
Queried whois.internic.net with “dom Pharmempire.com”…

Domain Name: PHARMEMPIRE.COM
Registry Domain ID: 1908754371_DOMAIN_COM-VRSN

Updated Date: 2016-04-28T05:44:47Z
Creation Date: 2015-03-10T12:41:18Z
Registry Expiry Date: 2020-03-10T12:41:18Z

Updated Date: 2015-05-10T02:36:07Z
Creation Date: 2015-03-10T12:41:18Z

Registrar Registration Expiration Date: 2020-03-10T12:41:18Z
Registrar: LogicBoxes Naming Services Ltd
Registrar IANA ID: 1745
Domain Status:
Registry Registrant ID: Not Available From Registry

Registrant Name: Michael Kodo
Registrant Organization:
Registrant Street: Schuilenburgerplein 24
Registrant City: Amersfoort
Registrant State/Province: XX
Registrant Postal Code: 3816TD
Registrant Country: NL
Registrant Phone: +31.0332854423
Registrant Email: michael.kodo@yahoo.com

Registry Admin ID: Not Available From Registry
Admin Name: Michael Kodo
Admin Organization:
Admin Street: Schuilenburgerplein 24
Admin City: Amersfoort
Admin State/Province: XX
Admin Postal Code: 3816TD
Admin Country: NL
Admin Phone: +31.0332854423
Admin Email: michael.kodo@yahoo.com

Registry Tech ID: Not Available From Registry
Tech Name: Michael Kodo
Tech Organization:
Tech Street: Schuilenburgerplein 24
Tech City: Amersfoort
Tech State/Province: XX
Tech Postal Code: 3816TD
Tech Country: NL
Tech Phone: +31.0332854423
Tech Email: michael.kodo@yahoo.com

Registrar: LogicBoxes Naming Services Ltd
Registrar IANA ID: 1745
Registrar Abuse Contact Email: abuse-contact@publicdomainregistry.com
Registrar Abuse Contact Phone: +1.2013775952

Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.PHARMEMPIRE.COM
Name Server: NS2.PHARMEMPIRE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint

>>> Last update of whois database: 2017-10-01T01:19:56Z <> Last update of WHOIS database: 2017-10-01T01:20:07Z <<<

FDA Warning Letter – Worldwide Drug Store

TO:       Worldwide Drug Store
FROM: The United States Food and Drug Administration
RE:        Notice of Unlawful Sale of Unapproved and Misbranded Drug Products to United  States Consumers over the Internet
DATE:  September 19, 2017
WARNING LETTER
The United States (U.S.) Food and Drug Administration (FDA) recently reviewed your websites (listed at the bottom of this letter) and determined that they offer products for sale in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). More specifically, the websites listed below offer unapproved new drugs and misbranded drugs for sale in U.S. commerce in violation of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the FD&C Act [21 U.S.C. §§ 331(a), 331(d), 331(k), 353(b), and 355(a)]. FDA requests that you immediately cease marketing violative drug products to U.S. consumers.
Unapproved New Drugs
As labeled, certain products offered for sale through your websites are drugs within the meaning of section 201(g) of the FD&C Act [21 U.S.C. § 321(g)] because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. These products, as marketed through your websites, are also new drugs as defined by section 201(p) of the FD&C Act [21 U.S.C. § 321(p)], because they are not generally recognized as safe and effective for their labeled uses.  New drugs may not be introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in section 505(a) of the FD&C Act [21 U.S.C. § 355(a)].  No approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] are in effect for these products. Accordingly, their introduction or delivery for introduction into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act [21 U.S.C. §§ 331(d) and 355(a)].
An example of an unapproved new drug on your websites is oral chloramphenicol. Your websites claim that chloramphenicol “is used for treating serious infections caused by certain bacteria.” There are currently no approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] in effect for oral chloramphenicol.  On September 21, 2016, it was announced in the Federal Register that FDA would not accept or approve abbreviated new drug applications (ANDAs) for chloramphenicol capsules, 50 mg, 100 mg, 250 mg, or chloramphenicol palmitate oral suspension, 150 mg/5 mL because FDA determined that previously approved versions of these chloramphenicol products were withdrawn from sale in the U.S. for reasons of safety or effectiveness. (81 FR 64914)
Prior to their removal from the market, the approved labeling for these products contained a boxed warning, commonly referred to as a “black box warning,” which is the strongest warning FDA requires, indicating the drug carries a significant risk of serious or life-threatening adverse effects. The boxed warning for chloramphenicol indicated that serious and sometimes fatal blood disorders [e.g., hypoplastic or aplastic anemia (very few or no blood cells in bone marrow), thrombocytopenia (low blood platelet counts), and granulocytopenia (low white blood cell counts)] are known to occur after administration of chloramphenicol. The boxed warning further described aplastic anemia attributed to chloramphenicol that later resulted in leukemia. In determining that these products were withdrawn from the market for reasons of safety or effectiveness, FDA relied on the fact that additional therapies with less severe adverse drug effects have been approved, and that the risks associated with these chloramphenicol products as labeled therefore outweighed the benefits.
Another example of an unapproved new drug product offered on your websites is roxithromycin, which your websites claim “is used for treating several different infections, including some STDs, upper and lower respiratory tract infections and asthma, gum infections like gingivitis, and bacterial infections associated with stomach and intestinal ulcers.”  There are currently no (and have never been) approved applications pursuant to section 505 of the FD&C Act
[21 U.S.C. § 355] in effect for roxithromycin in the U.S.
Misbranded Drugs
Your websites also offer prescription drugs for sale without a prescription.  Prescription products, as defined in FD&C Act § 503(b)(1) include those that, because of their toxicity or other potentiality for harmful effect, and/or the method of their use, and/or the collateral measures necessary for their use, are not safe for use except under supervision of a practitioner licensed by law to administer them. For example, both of the drugs identified above (chloramphenicol and roxithromycin) are prescription drugs as defined by FD&C Act §503(b)(1) offered for sale on your websites without a prescription. Chloramphenicol is associated with serious risks including, but not limited to, fatal aplastic anemia, and the approved labeling for this product, before it was withdrawn from sale, recommended extensive safety monitoring, including baseline blood studies followed by periodic blood studies approximately every 2 days.
Under U.S. law, prescription drug products can be dispensed only pursuant to a prescription from a healthcare practitioner licensed by law to administer prescription drugs. Your offering prescription drug products without requiring a prescription jeopardizes patient safety and misbrands the drug products under section 503(b)(1) of the FD&C Act [21 U.S.C. § 353(b)(1)]. Dispensing a prescription drug without a valid prescription is an act which results in the drug being misbranded while held for sale, in violation of section 301(k) of the FD&C Act [21 U.S.C. § 331(k)].
A drug is also misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)] if it fails to bear adequate directions for its intended use(s). “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5). Prescription drugs, as defined in section 503(b)(1)(A) of the FD&C Act [21 U.S.C. § 353(b)(1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner.
Because the aforementioned drugs are prescription drugs, intended for condition(s) that are not amenable to self- diagnosis and treatment by a layperson, adequate directions cannot be written such that a layperson can use the products safely for their intended use(s).  Consequently the labeling for these products fails to bear adequate directions for their intended use(s), causing them to be misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]. Because these drugs are not approved in the U.S., they are also not exempt under 21 CFR 201.115 from the requirements of section 502(f)(1) of the FD&C Act. By offering these drugs for sale to U.S. consumers, your websites are causing the introduction of misbranded drugs into interstate commerce in violation of section 301(a) of the FD&C Act [21 U.S.C. § 331(a)].
* * *
FDA is taking this action against Worldwide Drug Store because of the inherent risk to consumers who purchase unapproved new drugs and misbranded drugs.  Unapproved new drugs do not have the same assurance of safety and effectiveness as those drugs subject to FDA oversight, and drugs that have circumvented regulatory safeguards may be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether.
This letter is not intended to identify all the ways in which your activities might be in violation of law.  It is your responsibility to ensure that all products you market are in compliance with the FD&C Act and its implementing regulations.  You should take prompt action to correct the violations noted above as well as any other violations of the FD&C Act (which would include the offer for sale of all unapproved and/or misbranded drug products by your websites, not just the products noted above).  Failure to correct violations may result in FDA regulatory action, including seizure or injunction, without further notice.
Please notify this office in writing within 10 working days of receipt of this letter of any steps you have taken or will take to correct the violations set forth above and to prevent their recurrence.
If the corrective action(s) cannot be completed within 10 working days, state the reason for the delay and the time within which the correction(s) will be completed.  Your response and any other inquiries concerning this letter should be sent to FDA’s Internet Pharmacy Task Force at FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov.
 
 
Table of Websites:
                                                                   Connecting URL
buydrugsorderonline24.com
pharmacy-no-rx.com
cheapillsonline.com
buyzithromaxgeneric.net
buyzithromaxinusa.net
zithromaxonlinerxshop.net
buyciprofloxacinnorx.com
modernantibiotic.com
doxycyclinecheap.com
skypharmacy2016.com
canada-pharmacy-365.com
canadian-drugs-365.com
drug-24h.com
canadianpharmaciesmailorder.net
onlinedrugstore24hour.com
skypharmacyreview.com
silverpharmacy.com
medsnoprescriptiononline.com
antibioticseuromed.ru
antibioticsforsale.ru
antibioticsforsaleonline.ru
antibioticsonlineovernightdelivery.ru
antibioticsonlinepharmacy.ru
buyantibioticsonlineovernight.ru
buyantibioticswithoutprescriptionuk.ru
buyingantibioticsonline.ru
canadianonlinephamacyciproovernight.ru
flagyltablets.ru
mailorderantibiotics.ru
onlinedrugstore.ru
onlinepharmacywithoutaprescription.ru
tetracyclineantibioticsforsale.ru
cheapdrugs24h.net
antibioticsforsaleonline.life
bestcanadiantabs.com
trusted-generic-pharmacy.com
spiritual-health.org
pharmacy-365-pills.com
rxgolden.com
Sincerely,
/s/
Thomas Christl
Director
Office of Drug Security, Integrity, and Response
Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration

2017

Page Last Updated: 09/19/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی |English

FDA Warning Letter – Rx-Partners

TO:        Rx-Partners
FROM: The United States Food and Drug Administration
RE:        Notice of Unlawful Sale of Unapproved and Misbranded Drug Products to United States Consumers over the Internet
DATE:  September 19, 2017
WARNING LETTER
The United States (U.S.) Food and Drug Administration (FDA) recently reviewed your websites (listed at the bottom of this letter) and determined that they offer products for sale in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). More specifically, the websites listed below offer unapproved new drugs and misbranded drugs for sale in U.S. commerce in violation of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the FD&C Act [21 U.S.C. §§ 331(a), 331(d), 331(k), 353(b), and 355(a)]. FDA requests that you immediately cease marketing violative drug products to U.S. consumers.
Unapproved New Drugs
As labeled, certain products offered for sale through your websites are drugs within the meaning of section 201(g) of the FD&C Act [21 U.S.C. § 321(g)] because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. These products, as marketed through your websites, are also new drugs as defined by section 201(p) of the FD&C Act [21 U.S.C. § 321(p)], because they are not generally recognized as safe and effective for their labeled uses.  New drugs may not be introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in section 505(a) of the FD&C Act [21 U.S.C. § 355(a)].  No approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] are in effect for these products.  Accordingly, their introduction or delivery for introduction into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act [21 U.S.C. §§ 331(d) and 355(a)].
An example of an unapproved new drug on your websites is “Generic Chloromycetin (chloramphenicol).” Your websites claim “Generic Chloromycetin” is “an antibiotic that is clinically useful for serious infections caused by organisms susceptible to its antimicrobial effects when less potentially hazardous therapeutic agents are ineffective or contraindicated” and is “an effective remedy in some forms of meningitis caused by H.influenza, as well as diseases caused by typhoid and some other bacteria.” There are currently no approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] in effect for oral chloramphenicol.  On September 21, 2016, it was announced in the Federal Register that FDA would not accept or approve abbreviated new drug applications (ANDAs) for chloramphenicol capsules, 50 mg, 100 mg, 250 mg, or chloramphenicol palmitate oral suspension, 150 mg/5 mL because FDA determined that previously approved versions of these chloramphenicol products were withdrawn from sale in the U.S. for reasons of safety or effectiveness. (81 FR 64914)
Prior to their removal from the market, the approved labeling for these products contained a boxed warning, commonly referred to as a “black box warning,” which is the strongest warning FDA requires, indicating the drug carries a significant risk of serious or life-threatening adverse effects. The boxed warning for chloramphenicol indicated that serious and sometimes fatal blood disorders [e.g., hypoplastic or aplastic anemia (very few or no blood cells in bone marrow), thrombocytopenia (low blood platelet counts), and granulocytopenia (low white blood cell counts)] are known to occur after administration of chloramphenicol. The boxed warning further described aplastic anemia attributed to chloramphenicol that later resulted in leukemia. In determining that these products were withdrawn from the market for reasons of safety or effectiveness, FDA relied on the fact that additional therapies with less severe adverse drug effects have been approved, and that the risks associated with these chloramphenicol products as labeled therefore outweighed the benefits.
Misbranded Drugs
A drug is misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)] if it fails to bear adequate directions for its intended use(s). “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5).  Prescription drugs, as defined in section 503(b)(1)(A) of the FD&C Act [21 U.S.C. § 353(b)(1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner.
Because the aforementioned drugs are prescription drugs intended for condition(s) that are not amenable to self-diagnosis and treatment by a layperson, adequate directions cannot be written such that a layperson can use the products safely for their intended use(s). Consequently, the labeling for these products fails to bear adequate directions for their intended use(s), causing them to be misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]. Because these drugs are not approved in the U.S., they are also not exempt under 21 CFR 201.115 from the requirements of section 502(f)(1) of the FD&C Act. By offering these drugs for sale to U.S. consumers, your websites are causing the introduction of misbranded drugs into interstate commerce in violation of section 301(a) of the FD&C Act [21 U.S.C. § 331(a)].
Your websites also offer prescription drugs for sale without a prescription.  Prescription products, as defined in the FD&C Act § 503(b)(1) include those that, because of their toxicity or other potentiality for harmful effect, and/or the method of their use, and/or the collateral measures necessary for their use, are not safe for use except under supervision of a practitioner licensed by law to administer them. For example, both chloramphenicol and Levaquin (levofloxacin) are prescription drugs as defined by FD&C Act § 503(b)(1) offered for sale on your websites without a prescription. Chloramphenicol is associated with serious risks including, but not limited to, fatal aplastic anemia and the approved labeling for this product, before it was withdrawn from sale, the formerly FDA-approved chloramphenicol labeling recommended extensive safety monitoring, including baseline blood studies followed by periodic blood studies approximately every 2 days.
Levaquin is the brand name of a prescription drug approved by FDA to treat certain bacterial infections. The labeling for the FDA-approved drug Levaquin contains a boxed warning that addresses serious adverse reactions including tendinitis (tendon rupture or swelling of the tendon), peripheral neuropathy (changes in sensation and possible nerve damage), central nervous system effects (e.g., convulsions, dizziness, lightheadedness, increased intracranial pressure), and exacerbation of myasthenia gravis (a chronic disease that causes muscle weakness).
Under U.S. law, prescription drug products can be dispensed only pursuant to a prescription from a healthcare practitioner licensed by law to administer prescription drugs. Your offering prescription drug products without requiring a prescription jeopardizes patient safety and misbrands the drug products under section 503(b)(1) of the FD&C Act [21 U.S.C. § 353(b)(1)]. Dispensing a prescription drug without a valid prescription is an act which results in the drug being misbranded while held for sale, in violation of section 301(k) of the FD&C Act [21 U.S.C. § 331(k)].
* * *
FDA is taking this action against Rx-Partners because of the inherent risk to consumers who purchase unapproved new drugs and misbranded drugs.  Unapproved new drugs do not have the same assurance of safety and effectiveness as those drugs subject to FDA oversight, and drugs that have circumvented regulatory safeguards may be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether.
This letter is not intended to identify all the ways in which your activities might be in violation of law. It is your responsibility to ensure that all products you market are in compliance with the FD&C Act and its implementing regulations.  You should take prompt action to correct the violations noted above as well as any other violations of the FD&C Act (which would include the offer for sale of all unapproved and/or misbranded drug products by your websites, not just the products noted above).  Failure to correct violations may result in FDA regulatory action, including seizure or injunction, without further notice.
Please notify this office in writing within 10 working days of receipt of this letter of any steps you have taken or will take to correct the violations set forth above and to prevent their recurrence.
If the corrective action(s) cannot be completed within 10 working days, state the reason for the delay and the time within which the correction(s) will be completed.  Your response and any other inquiries concerning this letter should be sent to FDA’s Internet Pharmacy Task Force at FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov.
                                                                            Table of Websites:
Connecting URL
azithromycin250mg.net
azithromycintabs.net
24x7drugstoreonline.com
antibioticdoxycycline.com
colitex.net
highqualitydrugstore.com
rxtorg.com
abcmedline.com
viypharmacy.com
yvipharmacy.com
abeewell.net
doxycyclinehyclate.biz
trustedmedstore24.com
fast-meds-abroad.com
hq-medstore.com
qualitydrugstoregeneric.com
multiproductphshop.com
orderpharma.com
cheapantibioticsonline.com
drugsboat.com
rxnoprescription.com
thepharmacyone-rx.com
overthecounterpharma.com
antibioticshome.com
helpfultabs.com
safemedsrx.com
pills-24h.com
mdedrx.com
mdrxmd.com
worldhealthsupplier.com
choice7-24.com
ciprocost.com
zithromaxcanada.com
antiinfectivedrugs.com
edp2u.com
rxpillsstore.org
thebasil.net
noprescription-online-pharmacy24.com
norxpharmstore24.com
qualitydrugstorenow24.com
webgenericpharmacyonline24.com
webmedqualityshop24.com
medicinepricelist.com
topmednorx.com
Sincerely,
/s/
Thomas Christl
Director
Office of Drug Security, Integrity, and Response
Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration

2017

Page Last Updated: 09/19/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی 

FDA Warning Letter – Pharmempire

TO:        Pharmempire
FROM: The United States Food and Drug Administration
RE:        Notice of Unlawful Sale of Unapproved and Misbranded Drug Products to United States Consumers over the Internet
DATE:  September 19, 2017
WARNING LETTER
The United States (U.S.) Food and Drug Administration (FDA) recently reviewed your websites (listed at the bottom of this letter) and determined that they offer products for sale in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). More specifically, the websites listed below offer unapproved new drugs and misbranded drugs for sale in U.S. commerce in violation of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the FD&C Act [21 U.S.C. §§ 331(a), 331(d), 331(k), 353(b), and 355(a)]. FDA requests that you immediately cease marketing violative drug products to U.S. consumers.
Unapproved New Drugs
As labeled, certain products offered for sale through your websites are drugs within the meaning of section 201(g) of the FD&C Act [21 U.S.C. § 321(g)] because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. These products, as marketed through your websites, are also new drugs as defined by section 201(p) of the FD&C Act [21 U.S.C. § 321(p)], because they are not generally recognized as safe and effective for their labeled uses.  New drugs may not be introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in section 505(a) of the FD&C Act [21 U.S.C. § 355(a)].  No approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] are in effect for these products.  Accordingly, their introduction or delivery for introduction into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act [21 U.S.C. §§ 331(d) and 355(a)].
An example of an unapproved new drug on your websites is oral chloramphenicol. Your websites claim that chloramphenicol “is used for treating serious infections caused by certain bacteria.” There are currently no approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] in effect for oral chloramphenicol.  On September 21, 2016, it was announced in the Federal Register that FDA would not accept or approve abbreviated new drug applications (ANDAs) for chloramphenicol capsules, 50 mg, 100 mg, 250 mg, or chloramphenicol palmitate oral suspension, 150 mg/5 mL because FDA determined that previously approved versions of these chloramphenicol products were withdrawn from sale in the U.S. for reasons of safety or effectiveness. (81 FR 64914)
Prior to their removal from the market, the approved labeling for these products contained a boxed warning, commonly referred to as a “black box warning,” which is the strongest warning FDA requires, indicating the drug carries a significant risk of serious or life-threatening adverse effects. The boxed warning for chloramphenicol indicated that serious and sometimes fatal blood disorders [e.g., hypoplastic or aplastic anemia (very few or no blood cells in bone marrow), thrombocytopenia (low blood platelet counts), and granulocytopenia (low white blood cell counts)] are known to occur after administration of chloramphenicol. The boxed warning further described aplastic anemia attributed to chloramphenicol that later resulted in leukemia. In determining that these products were withdrawn from the market for reasons of safety or effectiveness, FDA relied on the fact that additional therapies with less severe adverse drug effects have been approved, and that the risks associated with these chloramphenicol products as labeled therefore outweighed the benefits.
Another example of an unapproved new drug product offered on your websites is roxithromycin, which your websites claim is “used for treating several different infections, including some STDs, upper and lower respiratory tract infections and asthma, gum infections like gingivitis, and bacterial infections associated with stomach and intestinal ulcers.”  There are currently no (and have never been) approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] in effect for roxithromycin in the U.S.
Misbranded Drugs
Your websites also offer prescription drugs for sale without a prescription.  Prescription products, as defined in the FD&C Act § 503(b)(1) include those that, because of their toxicity or other potentiality for harmful effect, and/or the method of their use, and/or the collateral measures necessary for their use, are not safe for use except under supervision of a practitioner licensed by law to administer them. For example, both of the drugs identified above (chloramphenicol and roxithromycin) are prescription drugs under FD&C Act § 503(b)(1) and are offered on your websites without a prescription. Chloramphenicol is associated with serious risks including, but not limited to, fatal aplastic anemia. Additionally, the formerly FDA-approved chloramphenicol labeling recommended extensive safety monitoring, including baseline blood studies followed by periodic blood studies approximately every 2 days.
Another example of a misbranded drug offered on your websites is Keflex (cephalexin). Keflex is the brand name of a prescription drug approved by FDA to treat certain bacterial infections. The labeling for the FDA-approved product Keflex includes significant risks, including but not limited to, warnings concerning serious allergic reactions, severe watery or bloody diarrhea, anemia, and seizures.
Under U.S. law, prescription drug products can be dispensed only pursuant to a prescription from a healthcare practitioner licensed by law to administer prescription drugs. Your offering prescription drug products without requiring a prescription jeopardizes patient safety and misbrands the drug products under section 503(b)(1) of the FD&C Act [21 U.S.C. § 353(b)(1)]. Dispensing a prescription drug without a valid prescription is an act which results in the drug being misbranded while held for sale, in violation of section 301(k) of the FD&C Act [21 U.S.C. § 331(k)].
A drug is also misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)] if it fails to bear adequate directions for its intended use(s).  “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5). Prescription drugs, as defined in section 503(b)(1)(A) of the FD&C Act [21 U.S.C. § 353(b)(1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner.
Because the aforementioned drugs are prescription drugs intended for condition(s) that are not amenable to self-diagnosis and treatment by a layperson, adequate directions cannot be written such that a layperson can use the products safely for their intended use(s).  Consequently, the labeling for these products fails to bear adequate directions for their intended use(s), causing them to be misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)]. Because these drugs are not approved in the U.S., they are also not exempt under 21 CFR 201.115 from the requirements of section 502(f)(1) of the FD&C Act. By offering these drugs for sale to U.S. consumers, your websites are causing the introduction of misbranded drugs into interstate commerce in violation of section 301(a) of the FD&C Act [21 U.S.C. § 331(a)].
* * *
FDA is taking this action against Pharmempire because of the inherent risk to consumers who purchase unapproved new drugs and misbranded drugs.  Unapproved new drugs do not have the same assurance of safety and effectiveness as those drugs subject to FDA oversight, and drugs that have circumvented regulatory safeguards may be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether.
This letter is not intended to identify all the ways in which your activities might be in violation of law.  It is your responsibility to ensure that all products you market are in compliance with the FD&C Act and its implementing regulations.  You should take prompt action to correct the violations noted above as well as any other violations of the FD&C Act (which would include the offer for sale of all unapproved and/or misbranded drug products by your websites, not just the products noted above).  Failure to correct violations may result in FDA regulatory action, including seizure or injunction, without further notice.
Please notify this office in writing within 10 working days of receipt of this letter of any steps you have taken or will take to correct the violations set forth above and to prevent their recurrence.
If the corrective action(s) cannot be completed within 10 working days, state the reason for the delay and the time within which the correction(s) will be completed.  Your response and any other inquiries concerning this letter should be sent to FDA’s Internet Pharmacy Task Force at FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov.
Table of Websites:
                                                        Connecting URL
canadian-pharma.com
good-pills.com
amoxilamoxicillinfor-sale.com
amoxil-amoxicillin-order.com
buyonlinewithoutprescriptionvia.org
buyonlinewithoutprescriptionwqc.org
metronidazole-flagylantibiotic.net
amoxicillincaamoxil.org
buy-ciprofloxacinhcl500mg.com
online-usapharmacy.com
amoxiluk.org
amoxicillinonlineamoxil.org
amoxicillin-amoxil-without-prescription.net
amoxilnoprescription-amoxicillin.net
hyclate-100mg-doxycycline.net
amoxicillinamoxil-buy.net
no-prescription-amoxil-amoxicillin.com
amoxicillinamoxil-order.com
amoxilamoxicillin-for-sale.com
caamoxilamoxicillin.net
online500mg-cipro.net
500mgorder-flagyl.net
amoxilamoxicillinorder.com
ciprofloxacin-hcl-buy-500mg.org
metronidazole-flagyl-buy.net
cipro-withoutprescriptiononline.com
amoxiluk-amoxicillin.org
orderamoxicillinamoxil.org
ciprofloxacin500mgbuy.mobi
online500mgcipro.net
rxpills101.com
1canadianxpills.com
canadianbestpills.com
online-amoxicillinamoxil.net
amoxil-for-saleamoxicillin.net
amoxilno-prescriptionamoxicillin.net
amoxicillinforsale-amoxil.net
online-buydoxycycline.org
flagyl-online-antibiotic.org
flagylantibiotic500mg.com
buy500mgciprofloxacinhcl.net
ciprofloxacin500mg-online.com
amoxilamoxicillin-forsale.org
amoxicillin-amoxil-buy.mobi
flagyl-metronidazole-antibiotic.mobi
amoxilfor-saleamoxicillin.com
amoxicillinamoxil-withoutprescription.com
withoutprescription-amoxicillinamoxil.org
buy500mg-ciprofloxacin-hcl.net
buy500mg-cipro.com
amoxicillin-amoxilonline.net
online500mgciprofloxacin.net
amoxil-without-prescription-amoxicillin.com
flagylmetronidazoleantibiotic.org
amoxilamoxicillinca.net
flagylmetronidazoleantibiotic.com
buy-amoxilamoxicillin.net
buy-tabletscipro.net
antibiotichelp.com
ciprofloxacinhcl-buy500mg.com
amoxil-amoxicillin-generic.net
ciprofloxacinbuy-500mg.net
100mg-doxycyclinemono.net
amoxicillin-online-amoxil.com
forsaleamoxil-amoxicillin.com
100mgdoxycycline-hyclate.org
ciprofloxacinhcl500mgbuy.com
buyantibiotic-flagyl.net
without-prescriptionamoxil-amoxicillin.com
buy-500mg-ciprofloxacin-hcl.org
flagylbuying.com
metronidazole500mg.biz
withoutprescription-amoxicillin-amoxil.com
metronidazole-flagylantibiotic.com
online-amoxicillin-amoxil.com
cipro500mg-buy.com
buyonlinewithoutprescriptionpiu.com
medicationsoverthecounter.com
pharmacyatwalmart.com
pharmexpress-rx.com
trustednorx.com
antibioticswithoutdoctorprescription.com
ciprofloxacin-hclbuy500mg.com
noprescriptionamoxilamoxicillin.net
amoxil-amoxicillinno-prescription.net
canadianpharmacy.tech
americanninedaylipost.com
genericviagraonlinenoscriptcheap.com
waytobehealthbluesea.com
sales-generic.com
amoxicillinamoxil-buy.com
pharmacyonline-noprescription.com
ciprofloxacin-hcl500mgtablets.com
buynoscriptwithoutpresctiptionotc.org
amoxicillinamoxilnoprescription.net
zithromax.me
bestpillsforsale.com
goldentabs.com
4rx-pharmacy.org
canadian-onlinepharmacy.com
canadian-pharmacy.website
canadianonlinepharmacy.website
planetmedpharmacy.com
tablrx.com
antibiotic-flagyl500mg.org

 

Sincerely,
/s/
Thomas Christl
Director
Office of Drug Security, Integrity, and Response
Office of Compliance
Center for Drug Evaluation and Research
Food and Drug Administration

2017

Page Last Updated: 09/19/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی |

FDA Warning Letter – PharmCash

TO:        PharmCash
FROM: The United States Food and Drug Administration
RE:        Notice of Unlawful Sale of Unapproved and Misbranded Drug Products to United States Consumers over the Internet
DATE:  September 19, 2017
WARNING LETTER
The United States (U.S.) Food and Drug Administration (FDA) recently reviewed your websites (listed at the bottom of this letter) and determined that they offer products for sale in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). More specifically, the websites listed below offer unapproved new drugs and misbranded drugs for sale in U.S. commerce in violation of sections 301(a), 301(d), 301(k), 503(b), and 505(a) of the FD&C Act [21 U.S.C. §§ 331(a), 331(d), 331(k), 353(b), and 355(a)]. FDA requests that you immediately cease marketing violative drug products to U.S. consumers.
Unapproved New Drugs
As labeled, certain products offered for sale through your websites are drugs within the meaning of section 201(g) of the FD&C Act [21 U.S.C. § 321(g)] because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. These products, as marketed through your websites, are also new drugs as defined by section 201(p) of the FD&C Act [21 U.S.C. § 321(p)], because they are not generally recognized as safe and effective for their labeled uses. New drugs may not be introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in section 505(a) of the FD&C Act [21 U.S.C. § 355(a)].  No approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] are in effect for these products. Accordingly, their introduction or delivery for introduction into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act [21 U.S.C. §§ 331(d) and 355(a)].
An example of an unapproved new drug on your websites is oral chloramphenicol offered for sale under the brand name, Chloromycetin. Your websites claim “[Chloramphenicol] is used to treat serious infectious diseases such as meningitis, rickettsial disease, salmonellosis and anaerobic infections.” There are currently no approved applications pursuant to section 505 of the FD&C Act [21 U.S.C. § 355] in effect for oral chloramphenicol.  On September 21, 2016, it was announced in the Federal Register that FDA would not accept or approve abbreviated new drug applications (ANDAs) for chloramphenicol capsules, 50 mg, 100 mg, 250 mg, or chloramphenicol palmitate oral suspension, 150 mg/5 mL because FDA determined that previously approved versions of these chloramphenicol products were withdrawn from sale in the U.S. for reasons of safety or effectiveness. (81 FR 64914)
Prior to their removal from the market, the approved labeling for these products contained a boxed warning, commonly referred to as a “black box warning,” which is the strongest warning FDA requires, indicating the drug carries a significant risk of serious or life-threatening adverse effects. The boxed warning for chloramphenicol indicated that serious and sometimes fatal blood disorders [e.g., hypoplastic or aplastic anemia (very few or no blood cells in bone marrow), thrombocytopenia (low blood platelet counts), and granulocytopenia (low white blood cell counts)] are known to occur after administration of chloramphenicol. The boxed warning further described aplastic anemia attributed to chloramphenicol that later resulted in leukemia. In determining that these products were withdrawn from the market for reasons of safety or effectiveness, FDA relied on the fact that additional therapies with less severe adverse drug effects have been approved, and that the risks associated with these chloramphenicol products as labeled therefore outweighed the benefits.
Misbranded Drugs
A drug is misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)] if it fails to bear adequate directions for its intended use(s).  “Adequate directions for use” means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5). Prescription drugs, as defined in section 503(b)(1)(A) of the FD&C Act [21 U.S.C. § 353(b)(1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner.
Because the aforementioned drugs are prescription products intended for condition(s) that are not amenable to self-diagnosis and treatment by a layperson, adequate directions cannot be written such that a layperson can use the products safely for their intended use(s).  Consequently, the labeling for these products fails to bear adequate directions for their intended use(s), causing them to be misbranded under section 502(f)(1) of the FD&C Act [21 U.S.C. § 352(f)(1)].  Because these drugs are not approved in the U.S., they are not exempt under 21 CFR 201.115 from the requirements of section 502(f)(1) of the FD&C Act. By offering these drugs for sale to U.S. consumers, your websites are causing the introduction of misbranded drugs into interstate commerce in violation of section 301(a) of the FD&C Act [21 U.S.C. § 331(a)].
Your websites also offer prescription drugs for sale without a prescription.  Prescription products, as defined in the FD&C Act § 503(b)(1) include those that, because of their toxicity or other potentiality for harmful effect, and/or the method of their use, and/or the collateral measures necessary for their use, are not safe for use except under supervision of a practitioner licensed by law to administer them. For example, both chloramphenicol and Levaquin (levofloxacin) are prescription drugs as defined in the FD&C Act §503(b)(1) and are offered for sale on your websites without a prescription. Chloramphenicol is associated with serious risks including, but not limited to, fatal aplastic anemia and the approved labeling for this product, before it was withdrawn from sale, recommended extensive safety monitoring, including baseline blood studies followed by periodic blood studies approximately every 2 days.
Levaquin is the brand name of a prescription drug approved by FDA to treat certain bacterial infections.  The labeling for the FDA-approved Levaquin product contains a boxed warning that addresses serious adverse reactions including tendinitis (tendon rupture or swelling of the tendon), peripheral neuropathy (changes in sensation and possible nerve damage), central nervous system effects (e.g., convulsions, dizziness, lightheadedness, increased intracranial pressure), and exacerbation of myasthenia gravis (a chronic disease that causes muscle weakness).
Under U.S. law, prescription drug products can be dispensed only pursuant to a prescription from a healthcare practitioner licensed by law to administer prescription drugs. Your offering prescription drug products without requiring a prescription jeopardizes patient safety and misbrands the drug products under section 503(b)(1) of the FD&C Act [21 U.S.C. § 353(b)(1)]. Dispensing a prescription drug without a valid prescription is an act which results in the drug being misbranded while held for sale, in violation of section 301(k) of the FD&C Act [21 U.S.C. § 331(k)].
* * *
FDA is taking this action against PharmCash because of the inherent risk to consumers who purchase unapproved new drugs and misbranded drugs.  Unapproved new drugs do not have the same assurance of safety and effectiveness as those drugs subject to FDA oversight, and drugs that have circumvented regulatory safeguards may be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether.
This letter is not intended to identify all the ways in which your activities might be in violation of law.  It is your responsibility to ensure that all products you market are in compliance with the FD&C Act and its implementing regulations.  You should take prompt action to correct the violations noted above as well as any other violations of the FD&C Act (which would include the offer for sale of all unapproved and/or misbranded drug products by your websites, not just the products noted above).  Failure to correct violations may result in FDA regulatory action, including seizure or injunction, without further notice.
Please notify this office in writing within 10 working days of receipt of this letter of any steps you have taken or will take to correct the violations set forth above and to prevent their recurrence.
If the corrective action(s) cannot be completed within 10 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response and any other inquiries concerning this letter should be sent to FDA’s Internet Pharmacy Task Force at FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov.
Table of Websites:
Connecting URL
buyacyclovirzovirax.net
buyflagylmetronidazole.net
buyingantibioticsonline.net
onlinepills.ca
nextdaydeliverys.com
doxycycline-pro.com
buyantibiotics24h.com
med-store.net
yourtrustprescriptionsupplier.net
buy-antibiotics.org
pillsfromcanada.com
myantibiotics.org
overnightsdeliverys.com
drugsincanada.com
goldmeds.net
md-q.com
fda-approved-rx.biz
best-pharma-shop.com
drug-rx-pharmacy.org
your-onlinepharmacy.com
store-rx.com
internetpharmacydir.com
antimicrobialmed.com
amoxil-amoxicillin-pro.com
atlantic-drugs.net
no-rxdrugs.com
rxmedsdoctor.net
without-prescription.com
mydreamrx.com
memotrax.com
asiapharm.net
commonrx.com
drugs-rx-pharmacy.com
onlineantibiotics.net
rxdownunder.com
greatpillonline.com

2017

Page Last Updated: 09/19/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی |English